Pfizer (PFE)
(Delayed Data from NYSE)
$29.97 USD
+0.26 (0.88%)
Updated Jul 19, 2024 04:02 PM ET
After-Market: $29.98 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Price, Consensus and EPS Surprise
PFE 29.97 +0.26(0.88%)
Will PFE be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PFE
Zacks Industry Outlook Eli Lilly, Novo Nordisk, Merck and Pfizer
Johnson & Johnson (JNJ) Beats Q2 Earnings and Revenue Estimates
PFE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Moderna (MRNA) Stock Rises 22% YTD: Time to Buy the Stock?
4 Large Drug Stocks to Watch as Innovation, M&A Pick Up
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Other News for PFE
Kamala Harris' potential impact on health care stocks
Ex-Dividend Date Nearing for These 10 Stocks – Week of July 22, 2024
Here are Big Pharma’s leading blockbuster makers
Dividend Champion, Contender, And Challenger Highlights: Week Of July 21
See Which Of The Latest 13F Filers Holds Pfizer